ZEAL (Zealand Pharma A/S ADR) stock is currently covered by 2 analysts. The average analyst rating is 3.5 out of 5.
ZEAL analysts have given it a high price target of $42, mean price target of $38.75, and a low price target of $35.5.
ZEAL currently has an estimated 12-Month price forecast of $38.75 based on the average analyst price target.
[wpdatatable id=10 var1=ZEAL]